Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Acq. announced
Consulting agrmnt
Director departure
CC transcript
|
|
NxStage Medical, Inc. (NXTM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Disposed/sold 781,646 shares
@ $30, valued at
$23.4M
Disposed/sold 39,062 options to buy
@ $18.48, valued at
$721.9k
Disposed/sold 189,456 options to buy
@ $11.03, valued at
$2.1M
Disposed/sold 175,256 options to buy
@ $14.66, valued at
$2.6M
Disposed/sold 205,058 options to buy
@ $16.66, valued at
$3.4M
Disposed/sold 268,159 options to buy
@ $15.58, valued at
$4.2M
Disposed/sold 149,567 options to buy
@ $27.89, valued at
$4.2M
Disposed/sold 34,928 restricted stock units
@ $0 |
|
| 02/25/2019 |
4
| TOWSE MATTHEW W (SVP and Chief Financial Office) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Disposed/sold 28,396 shares
@ $30, valued at
$851.9k
Disposed/sold 60,958 options to buy
@ $14.66, valued at
$893.6k
Disposed/sold 65,618 options to buy
@ $16.66, valued at
$1.1M
Disposed/sold 89,386 options to buy
@ $15.58, valued at
$1.4M
Disposed/sold 49,855 options to buy
@ $27.89, valued at
$1.4M
Disposed/sold 11,643 restricted stock units
@ $0 |
|
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
4
| Mixer Jean K (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Disposed/sold 16,012 shares
@ $30, valued at
$480.4k
Disposed/sold 23,394 options to buy
@ $13.16, valued at
$307.9k
Disposed/sold 19,724 options to buy
@ $16.81, valued at
$331.6k
Disposed/sold 15,854 options to buy
@ $18.32, valued at
$290.4k
Disposed/sold 15,643 options to buy
@ $22.78, valued at
$356.3k
|
|
| 02/25/2019 |
4
| MOORE CRAIG W (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Disposed/sold 3,745 shares
@ $30, valued at
$112.4k
Disposed/sold 105,439 shares
@ $30, valued at
$3.2M
Disposed/sold 23,394 options to buy
@ $13.16, valued at
$307.9k
Disposed/sold 19,724 options to buy
@ $16.81, valued at
$331.6k
Disposed/sold 15,854 options to buy
@ $18.32, valued at
$290.4k
Disposed/sold 15,643 options to buy
@ $22.78, valued at
$356.3k
|
|
| 02/25/2019 |
4
| Donigan Heyward R (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Disposed/sold 3,582 shares
@ $30, valued at
$107.5k
Disposed/sold 10,784 options to buy
@ $21.73, valued at
$234.3k
Disposed/sold 15,643 options to buy
@ $22.78, valued at
$356.3k
|
|
| 02/25/2019 |
4
| REID PERPER (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Disposed/sold 145,826 shares
@ $30, valued at
$4.4M
Disposed/sold 23,394 options to buy
@ $13.16, valued at
$307.9k
Disposed/sold 15,854 options to buy
@ $18.32, valued at
$290.4k
Disposed/sold 15,643 options to buy
@ $22.78, valued at
$356.3k
Disposed/sold 19,724 options to buy
@ $16.81, valued at
$331.6k
|
|
| 02/25/2019 |
4
| Giannini Daniel A (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Disposed/sold 81,389 shares
@ $30, valued at
$2.4M
Disposed/sold 23,394 options to buy
@ $13.16, valued at
$307.9k
Disposed/sold 19,724 options to buy
@ $16.81, valued at
$331.6k
Disposed/sold 15,854 options to buy
@ $18.32, valued at
$290.4k
Disposed/sold 15,643 options to buy
@ $22.78, valued at
$356.3k
|
|
| 02/25/2019 |
4
| FUNARI ROBERT G (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Disposed/sold 22,837 shares
@ $30, valued at
$685.1k
Disposed/sold 23,394 options to buy
@ $13.16, valued at
$307.9k
Disposed/sold 19,724 options to buy
@ $16.81, valued at
$331.6k
Disposed/sold 15,854 options to buy
@ $18.32, valued at
$290.4k
Disposed/sold 15,643 options to buy
@ $22.78, valued at
$356.3k
|
|
| 02/25/2019 |
4
| LEWIS EARL R (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Disposed/sold 100,232 shares
@ $30, valued at
$3M
Disposed/sold 23,394 options to buy
@ $13.16, valued at
$307.9k
Disposed/sold 19,724 options to buy
@ $16.81, valued at
$331.6k
Disposed/sold 15,854 options to buy
@ $18.32, valued at
$290.4k
Disposed/sold 15,643 options to buy
@ $22.78, valued at
$356.3k
|
|
| 02/25/2019 |
4
| Peters James J (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Disposed/sold 15,643 options to buy
@ $22.78, valued at
$356.3k
Disposed/sold 17,537 options to buy
@ $19.03, valued at
$333.7k
|
|
| 05/21/2018 |
4
| Turk Joseph E Jr (President) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Exercised 5,392 options to buy
@ $18.59, valued at
$100.2k
|
|
| 05/18/2018 |
4
| MOORE CRAIG W (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 3,955 shares
@ $26.48, valued at
$104.7k
Exercised 10,496 options to buy
@ $13.6, valued at
$142.7k
Exercised 7,700 options to buy
@ $13.6, valued at
$104.7k
|
|
| 05/18/2018 |
4
| REID PERPER (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Exercised 18,196 options to buy
@ $13.6, valued at
$247.5k
|
|
| 05/18/2018 |
4
| Giannini Daniel A (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Exercised 18,196 options to buy
@ $13.6, valued at
$247.5k
|
|
| 03/16/2018 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 28,039 shares
@ $24.05, valued at
$674.3k
Exercised 36,273 options to buy
@ $18.59, valued at
$674.3k
|
|
| 03/12/2018 |
4
| Turk Joseph E Jr (President) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 3,536 shares
@ $24.37, valued at
$86.2k
Granted 34,928 restricted stock units
@ $0
Exercised 11,642 restricted stock units
@ $0 |
|
| 03/12/2018 |
4
| Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 1,350 shares
@ $24.37, valued at
$32.9k
Granted 13,971 restricted stock units
@ $0
Exercised 4,657 restricted stock units
@ $0 |
|
| 03/12/2018 |
4
| TOWSE MATTHEW W (SVP and Chief Financial Office) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 1,846 shares
@ $24.37, valued at
$45k
Granted 17,464 restricted stock units
@ $0
Exercised 5,821 restricted stock units
@ $0 |
|
| 03/12/2018 |
4
| Burbank Jeffrey H (CEO) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 5,167 shares
@ $24.37, valued at
$125.9k
Granted 52,392 restricted stock units
@ $0
Exercised 17,464 restricted stock units
@ $0 |
|
| 02/22/2018 |
4
| Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 3,500 shares
@ $24.48, valued at
$85.7k
Exercised 3,000 options to buy
@ $11.03, valued at
$33.1k
|
|
| 01/19/2018 |
4
| Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 3,500 shares
@ $24.88, valued at
$87.1k
Exercised 3,000 options to buy
@ $11.03, valued at
$33.1k
|
|
| 12/21/2017 |
4
| Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 3,500 shares
@ $25.35, valued at
$88.7k
Exercised 3,000 options to buy
@ $11.03, valued at
$33.1k
|
|
| 12/14/2017 |
4
| FUNARI ROBERT G (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 12,682 shares
@ $25.89, valued at
$328.3k
Exercised 18,196 options to buy
@ $13.6, valued at
$247.5k
Exercised 7,173 options to buy
@ $11.27, valued at
$80.8k
|
|
| 11/29/2017 |
4
| LEWIS EARL R (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Gifted 8,554 shares
@ $0 |
|
| 11/15/2017 |
4
| Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 3,500 shares
@ $25.73, valued at
$90.1k
Exercised 3,000 options to buy
@ $11.03, valued at
$33.1k
|
|
| 10/04/2017 |
4
| Turk Joseph E Jr (President) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 1,000 shares
@ $27.56, valued at
$27.6k
|
|
| 09/21/2017 |
4
| Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 3,500 shares
@ $27.27, valued at
$95.4k
Exercised 3,000 options to buy
@ $11.03, valued at
$33.1k
|
|
| 09/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2017 |
4
| Mixer Jean K (Director) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Paid exercise price by delivering 8,889 shares
@ $27.84, valued at
$247.5k
Exercised 18,196 options to buy
@ $13.6, valued at
$247.5k
|
|
| 09/05/2017 |
4
| Turk Joseph E Jr (President) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 1,000 shares
@ $27.95, valued at
$28k
|
|
| 08/23/2017 |
4
| TOWSE MATTHEW W (SVP and Chief Financial Office) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 4,300 shares
@ $29.22, valued at
$125.6k
Exercised 4,300 options to buy
@ $14.05, valued at
$60.4k
|
|
| 08/15/2017 |
4
| Swan Winifred L (SVP and General Counsel) has filed a Form 4 on NxStage Medical, Inc.|
Txns:
| Sold 3,500 shares
@ $29.21, valued at
$102.2k
Exercised 3,000 options to buy
@ $11.03, valued at
$33.1k
|
|
|
|
|